Plunkett Research Online: Y-mAbs Therapeutics Inc

Y-MABS THERAPEUTICS INC (YMAB) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others......


Y-MABS THERAPEUTICS INC

Ticker: YMAB
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 646 885-8505
Fax:
Address: 230 Park Avenue Suite 3350
New York, NY 10169 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Michael RossiCEO/Director/President
Peter PfreundschuhCFO/Treasurer
See More
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others......See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture